Male breast cancer: about 123 cases collected at the Institute Salah-Azaiz of Tunis from 1979 to 1999

被引:0
|
作者
Ben Dhiab, T
Bouzid, T
Gamoudi, A
Ben Hassouna, J
Khomsi, F
Boussen, H
Benna, F
EL May, A
Hechiche, M
Rahal, K
机构
[1] Inst Salah Azaiz, Serv Chirurg Gen Carcinol, Tunis, Tunisia
[2] Inst Salah Azaiz, Ser Immunocytochim, Tunis, Tunisia
[3] Inst Salah Azaiz, Med Oncol Serv, Tunis, Tunisia
[4] Inst Salah Azaiz, Serv Radiotherapie, Tunis, Tunisia
关键词
male breast carcinomas; prognosis; survival; treatment;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Male breast cancer is rare compared to its female counterpart representing less than 1% of cancer in men. The objective of our retrospective study is to report the epidemiologic and clinical profile and to analyse the therapeutic results and prognostic factors in a Tunisian population collected during a period of 20 years at a single institution. We collected from 1979 to 1999, all the histological confirmed male breast cancers treated at oar institution. We analyse the following data: age, clinical presentation and features, therapeutic protocol. results and prognostic factors. Survival was done with the Kaplan-Meier method and comparison with the log-rank test. 123 cases of male breast carcinoma were collected with a median age of 65 years. Most patients (62.2%) have an advanced T4 disease with bilateral lesions in 4 cases. Infiltrating ductal carcinoma represent 91% of all tumours. 85% of tumours expressed hormonal receptor. The treatment consisted in a radical mastectomy in 93 cases (84%) followed by radiotherapy. chemotherapy and in many cases by hormonotherapy. After a median follow lip of 26 month, 22 patients presented loco regional recurrence and 4 7 metastases. Estimated 5-year survival rate was 62%. The presence of metastasis nodal involvement, advanced disease, and grade affected survival. Male breast cancer represent at our institution 1% of the male cancers treated comparable to the literature data. T4 tumours represent a higher rate, the treatment approach is the standard applicable in breast cancer prognostic factors arc, the classical one like breast cancer in women.
引用
收藏
页码:281 / 285
页数:5
相关论文
共 4 条
  • [1] Sentinel node in breast cancer. Experience of the Salah-Azaiz Institute of Tunis
    Hassouna, J. Ben
    Bouzid, T.
    Chkir, A.
    Kadri, N.
    Goucha, A.
    Slim, I.
    Boussen, H.
    Gamoudi, A.
    Hechiche, M.
    Dhiab, T. Ben
    Rahal, K.
    [J]. BULLETIN DU CANCER, 2010, 97 (04) : 453 - 460
  • [2] Inflammatory breast cancer. Experience of the Salah-Azaiz institute. Regarding 419 cases
    Rekik, W.
    Hammadi, F.
    Bouzaienne, H.
    Goucha, A.
    Ben Hassouna, J.
    Ouenniche, K.
    Khomsi, V
    Slimene, M.
    Shkir, A.
    Benna, F.
    Boussen, H.
    Rahal, K.
    Gamoudi, A.
    [J]. BULLETIN DU CANCER, 2008, 95 (06) : 607 - 607
  • [3] MALE BREAST CANCER: ABOUT 127 CASES COLLECTED AT THE NATIONAL INSTITUTE OF ONCOLOGY FROM 1985 TO 2007
    Bourhafour, M.
    Ghizlane, R.
    Amine, S.
    Yassir, S.
    Fouad, T.
    Gueddari, B.
    Hassan, E.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 107 - 107
  • [4] Male breast cancer:: A review of 52 cases collected at the Institute Bergonie (Bordeaux, France) from 1980 to 2004
    de Lara, C. Tunon
    Goudy, G.
    MacGrogan, G.
    Durand, M.
    Dilhuydy, J. -M.
    Avril, A.
    Stoeckle, E.
    Bussieres, J. -E.
    Debled, M.
    de Mascarel, I.
    Mauriac, L.
    [J]. GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2008, 36 (04): : 386 - 394